SEC Form 4 · accession 0001127602-17-021019
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Jun 8, 2017
Accepted (ET)
Jun 9, 2017 · 10:23 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2017 | M | 945 | $51.45 | A | 14,203 | D | |
| Common Stock | Jun 8, 2017 | S | 945 | $95.00 | D | 13,258 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $51.45 | Jun 8, 2017 | M | 945 | D | May 1, 2015 | May 1, 2021 | Common Stock | 945 | 17,762 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.